Home
Search
Category
Compounds
Status
Download
Contacts
Resources



Compound category: Organoheterocyclic compounds
(total 322 related compounds in database, current show from 311 to 320)
 
Compound name 2D structure Target pathogen(s) Related VF/VFcategory Max phase Reference(s)
2-(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)iminoindene-1,3-dione Depiction based on curated SMILES H 3 C N N O O H 3 C O N Yersinia TTSS secreted effectors Preclinical (in vitro) Hu X, et al. 2013. Bioorg Med Chem Lett
2-hydroxy-5-{5-[(E)-{2-[(5-phenyl-2H-tetrazol-2-yl)acetyl]hydrazinylidene}methyl]furan-2-yl}benzoic acid Depiction based on curated SMILES OH O HO O N N H O N N N N Yersinia TTSS secreted effectors Preclinical (in vitro) Tautz L, et al. 2005. J Biol Chem
3-(4-Chloro-phenyl)-1,6-dimethyl-1H-pyrimido[5,4-e][1,2,4]triazine-5,7-dione Depiction based on curated SMILES N O CH 3 N O N CH 3 Cl N N Yersinia TTSS secreted effectors Preclinical (in vitro) Hu X, et al. 2013. Bioorg Med Chem Lett
3,3'-(1,3,6,8-tetraoxo-1,3,6,8-tetrahydrobenzo[lmn]-3,8-phenanthroline-2,7-diyl)dipropanoic acid Depiction based on curated SMILES O O OH O O N O O N HO Yersinia TTSS secreted effectors Preclinical (in vitro) Eriksson J, et al. 2012. Adv Exp Med Biol
4-[1,3-dioxo-5-(4-oxo-4H-3,1-benzoxazin-2-yl)-1,3-dihydro-2H-isoindol-2-yl]benzoic acid Depiction based on curated SMILES OH O O N O N O O Yersinia TTSS secreted effectors Preclinical (in vitro) Hu X, et al. 2013. Bioorg Med Chem Lett
5-cyano-6-[(4-methylphenyl)methylsulfanyl]pyridine-2-carboxylic acid Depiction based on curated SMILES N N HO O CH 3 S Escherichia
Yersinia
TTSS (Type III secretion system)
TTSS (Type III secretion system)
Preclinical (in vitro)
Preclinical (in vitro)
Pan NJ, et al. 2009. Antimicrob Agents Chemother
5-[3'-(4-methylphenyl)-1'-phenyl-5-(2-thienyl)-3,4-dihydro-1'H,2H-3,4'-bipyrazol-2-yl]-5-oxopentanoic acid Depiction based on curated SMILES O S N N O OH N N CH 3 Yersinia TTSS (Type III secretion system) Preclinical (in vitro) Pan NJ, et al. 2009. Antimicrob Agents Chemother
5-({1-[(2-chloro-1,3-thiazol-5-yl)methyl]-1H-indol-3-yl}methylene)-1,3-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione Depiction based on curated SMILES Cl O CH 3 N O S H 3 C N N O N Yersinia TTSS secreted effectors Preclinical (in vitro) Hu X, et al. 2013. Bioorg Med Chem Lett
5-{3-bromo-4-[(4-nitrobenzyl)oxy]benzylidene}pyrimidine-2,4,6(1H,3H,5H)-trione Depiction based on curated SMILES _ O O + N Br O HN O NH O O Yersinia TTSS secreted effectors Preclinical (in vitro) Hu X, et al. 2013. Bioorg Med Chem Lett
5-[4-(3,4-dihydroisoquinolin-2(1H)-yl)-3-nitrobenzylidene]-2-thioxodihydropyrimidine-4,6(1H,5H)-dione Depiction based on curated SMILES N _ O O + N O O HN S N H Yersinia TTSS secreted effectors Preclinical (in vitro) Hu X, et al. 2013. Bioorg Med Chem Lett
   


NOTE: for more interactive and statistic charts, please visit the JavaScript-rich interface of VFDB.



Page 1  ...  22  23  24  25  26  27  28  29  30  31  32  33 



Back to top
2004-2024 NIPB, CAMS&PUMC